cysteamine has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Davis, JJ; Lehr, J; Patil, AV; Xu, Q | 1 |
| Alpaugh, M; Chen, X; Cicchetti, F; David, LS; Durcan, T; Lauinger, N; Saint-Pierre, M; Siddu, A | 1 |
2 other study(ies) available for cysteamine and alpha-synuclein
| Article | Year |
|---|---|
Graphene oxide interfaces in serum based autoantibody quantification.
Topics: alpha-Synuclein; Autoantibodies; Biosensing Techniques; Cysteamine; Electrochemical Techniques; Gold; Graphite; Humans; Limit of Detection; Microelectrodes; Parkinson Disease | 2015 |
Beneficial effects of cysteamine in Thy1-α-Syn mice and induced pluripotent stem cells with a SNCA gene triplication.
Topics: alpha-Synuclein; Animals; Cysteamine; Dopaminergic Neurons; Humans; Induced Pluripotent Stem Cells; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Parkinsonian Disorders | 2020 |